Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: As long as we are speculating

As long as we are speculating

posted on Dec 08, 2009 09:48AM

It's been mentioned that the CDX software probably could use some updating and perhaps some bells and whistles. I think there are people here that have insight with respect to where PTSC might be headed.

I recall someone mentioned combining AVOT tech with CDX and I think PTSC said they might explore that avenue.

Does anyone have insight as to what enhancements we would probably look for to make CDX more marketable? Can we assume that our target market is Govt based in light of Baroni and the bells and whistles would relate to those needs and perhaps the reason for latest BOD member?

Is it that simple?

GLTA, Opty

Share
New Message
Please login to post a reply